Coastar Therapeutics, Inc

Developing biological payload delivery technologies for immunotherapies and gene therapies. Incubated by Panacea, Coastar’s proprietary technology is a novel human erythrocyte-derived cell membrane encapsulation system that has many advantages related to immune system recognition and clearance